The 2016 WHO Classification of Myeloid Neoplasms

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 178 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Case Studies in Hematology - Malignant WBC Disorders. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Case Studies in Hematology - Malignant WBC Disorders (online CE course)
The 2016 WHO Classification of Myeloid Neoplasms

New molecular data is incorporated into some of the changes in the classification of myeloid neoplasms. Changes were made to existing categories, and a new category known as Myeloid Neoplasms with Germline Predisposition was added.
Among the many changes:
  • Myelodysplastic/Myeloproliferative Neoplasms with Ringed Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) was added.
  • New mutations were incorporated into the Myeloproliferative Neoplasms (MPN)
  • The Myelodysplastic Syndromes (MDS) were renamed, and new diagnostic criteria were incorporated into some of the categories; the term Refractory Anemia is no longer used, but rather MDS with the various descriptions of blasts and cytopenias